![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF is Safe and Well-Tolerated with Efficacy Comparable to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96
|
|
|
Reported by Jules Levin
4th International Workshop on HIV and Women, from Adolescence through Menopause
January 13-14, 2014 Washington DC, USA
C Creticos1, C McDonald2, S Segal-Maurer3, I Brar4, B Wade5, C Brinson6, W Garner7, D Porter7, T Fralich7, J DeMorin7, O Lugo-Torres7, E Elbert7
1Howard Brown Health Center, Chicago, IL; 2Tarrant County Infectious Disease, Fort Worth, TX, USA; 3New York Hospital Queens, Flushing, NY, USA; 4Henry Ford Hospital, Detroit, MI, USA; 5Center for Prevention/Treatment, Pensacola, FL, USA; 6Red River Family Practice, Austin, TX, USA; 7Gilead Sciences, Foster City, CA, USA
![Womens1.gif](../images/012114/012114-1/Womens1.gif)
![Womens2.gif](../images/012114/012114-1/Womens2.gif)
![Womens3.gif](../images/012114/012114-1/Womens3.gif)
![Womens4.gif](../images/012114/012114-1/Womens4.gif)
![Womens5.gif](../images/012114/012114-1/Womens5.gif)
![Womens6.gif](../images/012114/012114-1/Womens6.gif)
![Womens7.gif](../images/012114/012114-1/Womens7.gif)
![Womens8.gif](../images/012114/012114-1/Womens8.gif)
![Womens9.gif](../images/012114/012114-1/Womens9.gif)
![Womens10.gif](../images/012114/012114-1/Womens10.gif)
![Womens11.gif](../images/012114/012114-1/Womens11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|